Towards Healthcare
Hematology Analyzers Market to Soar USD 7.28 Billion in 2034

Hematology Analyzers Market 2025 Drives by AI Integration, CBC Dominance & POCT Expansion

According to market projections, the global hematology analyzers market, valued at USD 4.08 billion in 2024, is anticipated to reach USD 7.28 billion by 2034, growing at a CAGR of 5.97% over the next decade. Majorly impacting factors like rising prevalence of blood disorders such as anaemia, thalassemia, leukemia, and progressing innovations in pharmacogenomics, stem cell research are driving the market growth.

Content

  • Last Updated: 09 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The hematology analyzers market is projected to reach USD 7.28 billion by 2034, growing at a CAGR of 5.97% from 2024 to 2034.

North America is currently leading the hematology analyzers market due to high diagnostic volumes, chronic disease screening, and centralized lab chains.

The hematology analyzers market includes 6 segments, such as by product type, by technology, by application, by end user, by modality, and by region etc.

Some key players include Sysmex Corporation, Beckman Coulter (Danaher Corporation), Abbott Laboratories, Siemens Healthineers, and Horiba Ltd. 

Key trends include rising demand for advanced diagnostic equipment and POCT, growth in investments in healthcare infrastructure, and innovation in automated and AI-driven technologies in hematology.

A hematology analyzer provides information regarding CBC, differential WBC count, red blood cell indices, and platelet parameters.

Hematology analyzer has some common faults like counting small hole blockage, aspiration needle blockage, pump tube aging, filter is not smooth, directional valve failure, solenoid valve blockage, waste liquid cup accumulation, insufficient reagent volume, and sample volume shortage, and so on.

The main purpose of hematology includes blood and bone marrow cells. Also, hematological tests support to diagnosis of anemia, infection, hemophilia, blood-clotting disorders, and leukemia.

NIH.GOV, CDC.GOV, US FDA. GOV, PIB.GOV, MoHFW, ICMR, ISHBT, ASH.GOV, ACTREC.GOV
Any Questions